Cross-protective TH1 immunity against Aspergillus fumigatus and Candida albicans.
暂无分享,去创建一个
J. Latgé | S. Stevanović | H. Einsele | L. Romani | S. Bozza | S. Krappmann | J. Loeffler | S. Moretti | T. Zelante | N. Khanna | M. Topp | C. Stuehler | Sarah Lurati | Eike Worschech | Michaela Kruhm | Barbara Conrad | Claudia Stuehler
[1] J. Latgé,et al. Cross-Reactive TH1 Cells to Aspergillus Fumigatus and Candida Albicans , 2010 .
[2] S. Green,et al. Altered effector functions of virus‐specific and virus cross‐reactive CD8+ T cells in mice immunized with related flaviviruses , 2010, European journal of immunology.
[3] J. Staab,et al. Healthy Human T-Cell Responses to Aspergillus fumigatus Antigens , 2010, PloS one.
[4] Hao Liu,et al. Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients. , 2010, Blood.
[5] S. Dalai,et al. Suboptimal engagement of the T‐cell receptor by a variety of peptide–MHC ligands triggers T‐cell anergy , 2010, Immunology.
[6] H. Einsele,et al. Identification of Low Frequency Multiple Novel Aspergillus Fumigatus Specific MHC Class II Epitopes and Rapid Generation of An Aspergillus -Specific T-Cell Product Based On Activation Dependent Expression of CD154. , 2009 .
[7] Katia Perruccio,et al. Surface hydrophobin prevents immune recognition of airborne fungal spores , 2009, Nature.
[8] A. Beauvais,et al. Immune Sensing of Aspergillus Fumigatus Proteins, Glycolipids, and Polysaccharides and the Impact on Th Immunity and Vaccination 1 Materials and Methods A. Fumigatus Strain and Infection the Journal of Immunology , 2009 .
[9] J. Latgé,et al. Immune Responses of Human Immature Dendritic Cells Can Be Modulated by the Recombinant Aspergillus fumigatus Antigen Aspf1 , 2009, Clinical and Vaccine Immunology.
[10] P. Puccetti,et al. Balancing inflammation and tolerance in vivo through dendritic cells by the commensal Candida albicans , 2009, Mucosal Immunology.
[11] D. Stevens,et al. Saccharomyces cerevisiae as a vaccine against coccidioidomycosis. , 2009, Vaccine.
[12] A. Becker,et al. CD8+ T-cell clones dominate brain infiltrates in Rasmussen encephalitis and persist in the periphery. , 2009, Brain : a journal of neurology.
[13] Francisco A. Chaves,et al. Infection of HLA-DR1 Transgenic Mice with a Human Isolate of Influenza A Virus (H1N1) Primes a Diverse CD4 T-Cell Repertoire That Includes CD4 T Cells with Heterosubtypic Cross-Reactivity to Avian (H5N1) Influenza Virus , 2009, Journal of Virology.
[14] A. Barrett,et al. Scientific consultation on cell mediated immunity (CMI) in dengue and dengue vaccine development. , 2009, Vaccine.
[15] K. Marr. Fungal infections in hematopoietic stem cell transplant recipients. , 2008, Medical mycology.
[16] L. Lombardelli,et al. T cells specific for Candida albicans antigens and producing type 2 cytokines in lesional mucosa of untreated HIV-infected patients with pseudomembranous oropharyngeal candidiasis. , 2008, Microbes and infection.
[17] D. Margolis,et al. Stimulation by means of dendritic cells followed by Epstein–Barr virus‐transformed B cells as antigen‐presenting cells is more efficient than dendritic cells alone in inducing Aspergillus f16‐specific cytotoxic T cell responses , 2007, Clinical and experimental immunology.
[18] Bernard Malissen,et al. What guides MHC-restricted TCR recognition? , 2007, Seminars in immunology.
[19] J. Latgé,et al. The GPI‐anchored Gas and Crh families are fungal antigens , 2007, Yeast.
[20] Francisco A. Chaves,et al. The impact of DM on MHC class II–restricted antigen presentation can be altered by manipulation of MHC–peptide kinetic stability , 2006, The Journal of experimental medicine.
[21] D. Underhill,et al. Dectin-1 and TLRs Permit Macrophages to Distinguish between Different Aspergillus fumigatus Cellular States1 , 2006, The Journal of Immunology.
[22] J. Latgé,et al. Generation of highly purified and functionally active human TH1 cells against Aspergillus fumigatus. , 2006, Blood.
[23] A. Tosti,et al. Transferring functional immune responses to pathogens after haploidentical hematopoietic transplantation. , 2005, Blood.
[24] R. Rappuoli,et al. A novel glyco-conjugate vaccine against fungal pathogens , 2005, The Journal of experimental medicine.
[25] F. Brasseur,et al. Electroporation of immature and mature dendritic cells: implications for dendritic cell-based vaccines , 2005, Gene Therapy.
[26] T. Walsh,et al. Inteferon gamma and granulocyte-macrophage colony-stimulating factor augment the antifungal activity of human polymorphonuclear leukocytes against Scedosporium spp.: comparison with Aspergillus spp. , 2005, Medical mycology.
[27] L. Romani. Immunity to fungal infections , 2004, Nature Reviews Immunology.
[28] G. Rasi,et al. Thymosin alpha 1 activates dendritic cells for antifungal Th1 resistance through toll-like receptor signaling. , 2004, Blood.
[29] H. Einsele,et al. Rapid generation of combined CMV-specific CD4+ and CD8+ T-cell lines for adoptive transfer into recipients of allogeneic stem cell transplants. , 2004, Blood.
[30] J. Latgé,et al. Aspergillus fumigatus antigens activate innate immune cells via toll‐like receptors 2 and 4 , 2004, British journal of haematology.
[31] G. Pawelec. Extrathymic T-cell differentiation in vitro , 2004, Nature Reviews Immunology.
[32] J. Latgé,et al. Analysis of T-cell responses to Aspergillus fumigatus antigens in healthy individuals and patients with hematologic malignancies. , 2002, Blood.
[33] D. Pietrella,et al. Mannoprotein from Cryptococcus neoformans Promotes T-Helper Type 1 Anticandidal Responses in Mice , 2002, Infection and Immunity.
[34] S. Riddell,et al. Highly efficient gene transfer into baboon marrow repopulating cells using GALV-pseudotype oncoretroviral vectors produced by human packaging cells. , 2002, Blood.
[35] V. Kurup,et al. Vaccination of mice against invasive aspergillosis with recombinant Aspergillus proteins and CpG oligodeoxynucleotides as adjuvants. , 2002, Microbes and infection.
[36] Raymond M. Welsh,et al. No one is naive: the significance of heterologous T-cell immunity , 2002, Nature Reviews Immunology.
[37] C. Montagnoli,et al. Dendritic Cells Transport Conidia and Hyphae of Aspergillus fumigatus from the Airways to the Draining Lymph Nodes and Initiate Disparate Th Responses to the Fungus1 , 2002, The Journal of Immunology.
[38] M. Martelli,et al. Defective antifungal T-helper 1 (TH1) immunity in a murine model of allogeneic T-cell-depleted bone marrow transplantation and its restoration by treatment with TH2 cytokine antagonists. , 2001, Blood.
[39] Thierry Fontaine,et al. Glycosylphosphatidylinositol-anchored Glucanosyltransferases Play an Active Role in the Biosynthesis of the Fungal Cell Wall* , 2000, The Journal of Biological Chemistry.
[40] U. Reichard,et al. Molecular cloning and targeted deletion of PEP2 which encodes a novel aspartic proteinase from Aspergillus fumigatus. , 2000, International journal of medical microbiology : IJMM.
[41] R. Hay,et al. Production and Characterization of RecombinantAspergillus fumigatus Cu,Zn Superoxide Dismutase and Its Recognition by Immune Human Sera , 2000, Journal of Clinical Microbiology.
[42] H. Rammensee,et al. SYFPEITHI: database for MHC ligands and peptide motifs , 1999, Immunogenetics.
[43] J. Latgé,et al. Aspergillus fumigatus and Aspergillosis , 1999, Clinical Microbiology Reviews.
[44] D. Mason,et al. A very high level of crossreactivity is an essential feature of the T-cell receptor. , 1998, Immunology today.
[45] J. Shea,et al. Probing the active site of mitogillin, a fungal ribotoxin , 1998, Molecular microbiology.
[46] J. Nemunaitis,et al. Use of macrophage colony-stimulating factor in the treatment of fungal infections. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[47] J. Latgé,et al. Cloning and disruption of the antigenic catalase gene of Aspergillus fumigatus , 1997, Infection and immunity.
[48] A. Mccarthy. Development , 1996, Current Opinion in Neurobiology.
[49] N. Shastri,et al. Expression of endogenous peptide-major histocompatibility complex class II complexes derived from invariant chain-antigen fusion proteins. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[50] K. Uhlig,et al. Enhancement of oxidative response and damage caused by human neutrophils to Aspergillus fumigatus hyphae by granulocyte colony-stimulating factor and gamma interferon , 1993, Infection and immunity.
[51] P. Charmley,et al. The extent of the human germline T-cell receptor V beta gene segment repertoire , 2004, Immunogenetics.
[52] M. Oudshoorn,et al. Minimal phenotype panels. A method for achieving maximum population coverage with a minimum of HLA antigens. , 1996, Human immunology.
[53] P. Gregersen,et al. Oligoclonality of CD8+ T cells in multiple sclerosis. , 1996, Autoimmunity.